J.P. Morgan analyst Chris Schott maintained a Buy rating on Perrigo Company (PRGO – Research Report) today and set a price target of ...
Report with the AI impact on market trends- The global sexually transmitted disease (STD) testing market size is estimated to ...
Zacks.com on MSN6h
Gilead, MRK Report Data From Investigational Combination Study for HIVGilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...
On 4 November, Knut Steffensen will be taking up office as the director of the Karolinska ATMP Centre, a leading centre for advanced therapy medicinal products, with research, manufacture and ...
Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) and keeping the ...
DelveInsight's Antibody-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...
With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, ...
Cellular therapy, a revolutionary approach where cells are manipulated outside the body and then reintroduced to treat or prevent diseases, has been recognized in recent years as a highly promising ...
The 1) Market is expected to reach a substantial USD 34.83 billion by 2033, according to a new report. This reflects a ...
The global kinase inhibitor in autoimmune diseases market is projected to grow steadily over the next decade, according to a ...
Leerink has upgraded Gilead Sciences (GILD) to outperform, citing the growth outlook for its PrEP medication lenacapavir for ...
Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback